C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1999
12/29/1999	EP0966484A1 Neurotactin and uses therefor
12/29/1999	EP0822993B1 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene kai1
12/29/1999	EP0625048B1 Synthesis of human procollagens and collagens in recombinant dna systems
12/29/1999	EP0556292B1 Hepatitis c virus asialoglycoproteins
12/29/1999	CN1240000A Polypeptides encoded by human lipase-like gene, compositions and methods
12/29/1999	CA2690395A1 Use of bi-specific antibodies for pre-targeting diagnosis and therapy
12/29/1999	CA2335585A1 Novel molecules of the t110-related protein family and uses thereof
12/29/1999	CA2331924A1 Propionibacterium vector
12/29/1999	CA2331769A1 Prostate cancer-associated genes
12/29/1999	CA2331200A1 Olfactory receptors and their uses
12/29/1999	CA2330542A1 Human arf-related proteins
12/29/1999	CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/28/1999	US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules
12/28/1999	US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999	US6008327 Antibodies to the epstein-barr virus, comprising of viral capsid antigen proteins; diagnosis and therapy for burkitt's lymphoma, nasopharyngeal cancer
12/28/1999	US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999	US6008199 Continuously infusing an activated protein c for about 24 to 144 hours
12/28/1999	US6008194 Human preprotachykinin B
12/28/1999	US6008050 A polynucleotide encoding a polypeptide related to g protein coupled 7 transmembrane receptors; diagnosis/therapy of heart diseases, osteoporosis, anxiety, eating disorders, schizophrenia, ulcers, parkinson's/huntington's disease
12/28/1999	US6008041 Bovine dipeptidylaminopeptidase 1
12/28/1999	US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999	US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999	US6008024 An protein which forms an immunological complex with a phosphorylated epitope of an antigen belonging to a paired helical filament-tau protein; diagnosis and therapy for alzheimer's disease
12/28/1999	US6008017 Human cardiac/brain tolloid-like protein
12/28/1999	US6008015 Glycine transporter
12/28/1999	US6007981 Modifying target cells making them sensative to a toxin; transforming cells with a nucleotide sequences encoding a receptor that binds cryia toxin of bacillus, culturing cells allowing receptor expression on cell surface
12/28/1999	US6007817 Vasopermeability enhancing immunoconjugates
12/28/1999	US6007807 Hybrid fusion cell comprising idiotypic antibody-expressing malignant b cell fused to b cell hybridoma expressing an antibody which is internalized on an antigen presenting cell
12/28/1999	CA2151586C Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests
12/28/1999	CA2143163C Peptides derived from a retrovirus of the hiv group, and their use
12/28/1999	CA2068734C Mutants or variants of bacillus thuringiensis producing high yields of delta endotoxin
12/28/1999	CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999	CA1340863C Domain-modified constant region antibodies
12/28/1999	CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/28/1999	CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999	WO1999066054A2 Erythropoietin analog-human serum albumin fusion protein
12/23/1999	WO1999066053A1 Expression vector for use in a one-step purification protocol
12/23/1999	WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999	WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	WO1999066044A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999	WO1999066040A1 Immunomodulator polypeptide, zsig57
12/23/1999	WO1999066038A1 Angiostatin-binding protein
12/23/1999	WO1999066024A1 Methods of monitoring disease states and therapies using gene expression profiles
12/23/1999	WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999	WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999	WO1999065520A1 Egg surface proteins and methods for use for modulating fertility
12/23/1999	WO1999055832A3 Nucleic acid encoding rate agouti related protein
12/23/1999	WO1999047649A3 Polymerase chimeras
12/23/1999	WO1999042589A3 Insecticidal toxins from photorhabdus
12/23/1999	WO1999033871A3 Essential bacterial genes and their use
12/23/1999	WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999	WO1999025864A3 HIGH MOLECULAR WEIGHT η-POLY(GLUTAMIC ACID)
12/23/1999	DE19822122A1 Humane deadenylierende Nuclease, ihre Herstellung und Verwendung Human deadenylierende nuclease, their preparation and use
12/23/1999	CA2335299A1 Methods of monitoring disease states and therapies using gene expression profiles
12/23/1999	CA2333602A1 Expression vector for use in a one-step purification protocol
12/23/1999	CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999	CA2331880A1 Bactericidal/permeability-increasing protein (bpi) deletion analogs
12/23/1999	CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999	CA2331253A1 Immunomodulator polypeptide, zsig57
12/23/1999	CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999	CA2330527A1 Erythropoietin analog-human serum albumin fusion
12/23/1999	CA2330228A1 Angiostatin-binding protein
12/22/1999	EP0965644A2 Ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/22/1999	EP0965638A2 G-CSF analog compositions and methods
12/22/1999	EP0965597A1 Cell membrane-directed drugs
12/22/1999	EP0965594A2 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein
12/22/1999	EP0964926A1 IN VITRO PRODUCTION OF PROTEINS BY TRANSLATION OF mRNA
12/22/1999	EP0964925A2 A basal cell carcinoma tumor suppressor gene
12/22/1999	EP0964875A1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption
12/22/1999	EP0964870A2 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/22/1999	EP0964868A1 Isolated peptides derived from mage-2
12/22/1999	EP0964740A1 Polyasparaginic acid homopolymers and copolymers, biotechnical production and use thereof
12/22/1999	EP0964699A1 NUCLEIC ACID AND AMINO ACID SEQUENCES RELATING TO $i(HELICOBACTER PYLORI) AND VACCINE COMPOSITIONS THEREOF
12/22/1999	EP0964696A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
12/22/1999	EP0964693A1 Novel bacteriocins, transport and vector system and method of use thereof
12/22/1999	EP0726954B1 Cytokine antagonists
12/22/1999	CN1239515A Method for diagnosing bone dysbolism
12/22/1999	CN1239510A Compsns. and methods for treating disease states with myeloid progenitor inhibitory factor-1(MPIF-1), monocyte colony inhibitory factor (M-CIF) and macrophage inhibitory factor-4(MIP-4)
12/22/1999	CN1239479A Mage-1- encoding cDNA, tumor rejection antigen precursor mage-10, antibodies specific to molecule, and uses thereof
12/22/1999	CN1047666C Immunity detection method of releasing antigen from antibodies
12/21/1999	US6005091 Nucleic acids encoding immunoglobulin domains
12/21/1999	US6005082 Process for purification of factor VIII
12/21/1999	US6005080 Nucleotide sequences and expression vectors encoding hu-b1.219 gene product; molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis
12/21/1999	US6005079 Used for diagnosis or therapeutical purposes including protection against pathological agents or regulation of the expression or activity of proteins
12/21/1999	US6005075 Purification; use in antitumor and/or antiviral treatment
12/21/1999	US6005074 Cloning of human GPR14 receptor
12/21/1999	US6004940 Gene expression; nucleic acid segment encoding variable heavy chain sequence of antibody which selectively binds antigen
12/21/1999	US6004931 Method for inhibiting growth hormone action
12/21/1999	US6004925 Polypeptide anticholesterol agents; cardiovascular disorders, restenosis, atherosclerosis
12/21/1999	US6004811 Isolated cytotoxic t-cell which expresses a membrane-bound chimeric receptor which binds target cell and signals to destroy bound target cell; targets infected, cancerous, tumor or autoimmune-generated cells
12/21/1999	US6004797 Adenovirus helper-free recombinant AAV Virion production
12/21/1999	US6004796 Amino acid sequence of enzyme effective in removal of arginine, phenylalanine or methionine from the n-terminal end of peptides in peptide or peptidomimetic synthesis
12/21/1999	US6004794 Human serine protease
12/21/1999	US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999	US6004777 Vectors having enhanced expression, and methods of making and uses thereof
12/21/1999	US6004746 Interaction trap systems for detecting protein interactions
12/21/1999	US6004557 Variants of human papillomavirus antigens
12/21/1999	US6004554 Methods for targeting the vasculature of solid tumors
12/21/1999	US6004553 Inhibitors of tumor necrosis factor receptor associated factor-(traf) mediated signal transduction; use in screening assays and as pharmaceuticals
12/21/1999	US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell

1 ... 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 ... 1125